Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30

$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Bio Essence's EV/EBITDA was 13.8× on Oct 19, 2026.

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	13.8×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIOE.

Revenue growth435.2% · median 59.0%

Gross margin68.4% · median 44.3%

Operating margin45.1% · median -295.0%

Net margin44.7% · median -275.7%

Advertisement
300 × 250

See a number that looks wrong?